Human immunoglobulin G hinge regulates agonistic anti-CD40 immunostimulatory and antitumour activities through biophysical flexibility
Published 2019 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Human immunoglobulin G hinge regulates agonistic anti-CD40 immunostimulatory and antitumour activities through biophysical flexibility
Authors
Keywords
-
Journal
Nature Communications
Volume 10, Issue 1, Pages -
Publisher
Springer Science and Business Media LLC
Online
2019-09-27
DOI
10.1038/s41467-019-12097-6
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- The Immune Revolution: A Case for Priming, Not Checkpoint
- (2018) Robert H. Vonderheide CANCER CELL
- Complex Interplay between Epitope Specificity and Isotype Dictates the Biological Activity of Anti-human CD40 Antibodies
- (2018) Xiaojie Yu et al. CANCER CELL
- Structure-based engineering to restore high affinity binding of an isoform-selective anti-TGFβ1 antibody
- (2018) Dana M. Lord et al. mAbs
- The promise and challenges of immune agonist antibody development in cancer
- (2018) Patrick A. Mayes et al. NATURE REVIEWS DRUG DISCOVERY
- Cancer immunotherapy using checkpoint blockade
- (2018) Antoni Ribas et al. SCIENCE
- Consensus Bayesian assessment of protein molecular mass from solution X-ray scattering data
- (2018) Nelly R. Hajizadeh et al. Scientific Reports
- Structural characterization of the Man5 glycoform of human IgG3 Fc
- (2017) Ishan S. Shah et al. MOLECULAR IMMUNOLOGY
- ATSAS 2.8: a comprehensive data analysis suite for small-angle scattering from macromolecular solutions
- (2017) D. Franke et al. JOURNAL OF APPLIED CRYSTALLOGRAPHY
- Combination immunotherapy: a road map
- (2017) Patrick A. Ott et al. Journal for ImmunoTherapy of Cancer
- Therapeutic Activity of Agonistic, Human Anti-CD40 Monoclonal Antibodies Requires Selective FcγR Engagement
- (2016) Rony Dahan et al. CANCER CELL
- Bispecific Anti-HIV-1 Antibodies with Enhanced Breadth and Potency
- (2016) Stylianos Bournazos et al. CELL
- Human IgG1, IgG3, and IgG3 Hinge-Truncated Mutants Show Different Protection Capabilities against Meningococci Depending on the Target Antigen and Epitope Specificity
- (2016) S. Giuntini et al. Clinical and Vaccine Immunology
- Immunoglobulin isotype knowledge and application to Fc engineering
- (2016) Randall J Brezski et al. CURRENT OPINION IN IMMUNOLOGY
- Cancer immunotherapy: activating innate and adaptive immunity through CD40 agonists
- (2016) Gregory L. Beatty et al. Expert Review of Anticancer Therapy
- The new NCPSS BL19U2 beamline at the SSRF for small-angle X-ray scattering from biological macromolecules in solution
- (2016) Na Li et al. JOURNAL OF APPLIED CRYSTALLOGRAPHY
- Conformation of the Human Immunoglobulin G2 Hinge Imparts Superagonistic Properties to Immunostimulatory Anticancer Antibodies
- (2015) Ann L. White et al. CANCER CELL
- Terbium-based time-gated Förster resonance energy transfer imaging for evaluating protein–protein interactions on cell membranes
- (2015) Stina Lindén et al. DALTON TRANSACTIONS
- Structure of full-length human anti-PD1 therapeutic IgG4 antibody pembrolizumab
- (2015) Giovanna Scapin et al. NATURE STRUCTURAL & MOLECULAR BIOLOGY
- Structure of full-length human anti-PD1 therapeutic IgG4 antibody pembrolizumab
- (2015) Giovanna Scapin et al. NATURE STRUCTURAL & MOLECULAR BIOLOGY
- In-depth analysis of subclass-specific conformational preferences of IgG antibodies
- (2015) Xinsheng Tian et al. IUCrJ
- Advanced ensemble modelling of flexible macromolecules using X-ray solution scattering
- (2015) Giancarlo Tria et al. IUCrJ
- Open and Closed Conformations of the Isolated Transmembrane Domain of Death Receptor 5 Support a New Model of Activation
- (2014) Andrew K. Lewis et al. BIOPHYSICAL JOURNAL
- Inhibitory Fc Receptor Is Required for the Maintenance of Tolerance through Distinct Mechanisms
- (2014) F. Li et al. JOURNAL OF IMMUNOLOGY
- Agonistic CD40 Antibodies and Cancer Therapy
- (2013) R. H. Vonderheide et al. CLINICAL CANCER RESEARCH
- Oncology Meets Immunology: The Cancer-Immunity Cycle
- (2013) Daniel S. Chen et al. IMMUNITY
- IgG2 Fc structure and the dynamic features of the IgG CH2–CH3 interface
- (2013) Alexey Teplyakov et al. MOLECULAR IMMUNOLOGY
- Time-Resolved FRET -Based Approach for Antibody Detection – A New Serodiagnostic Concept
- (2013) Satu Saraheimo et al. PLoS One
- Antitumor activities of agonistic anti-TNFR antibodies require differential Fc RIIB coengagement in vivo
- (2013) F. Li et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Engineered antibody Fc variant with selectively enhanced Fc RIIb binding over both Fc RIIaR131 and Fc RIIaH131
- (2013) F. Mimoto et al. PROTEIN ENGINEERING DESIGN & SELECTION
- Role of Crosslinking for Agonistic CD40 Monoclonal Antibodies as Immune Therapy of Cancer
- (2013) L. P. Richman et al. Cancer Immunology Research
- A general requirement for FcγRIIB co-engagement of agonistic anti-TNFR antibodies
- (2012) Fubin Li et al. CELL CYCLE
- How Random are Intrinsically Disordered Proteins? A Small Angle Scattering Perspective
- (2012) Veronique Receveur-Brechot et al. CURRENT PROTEIN & PEPTIDE SCIENCE
- Apoptotic and antitumor activity of death receptor antibodies require inhibitory Fc receptor engagement
- (2012) F. Li et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Mouse model recapitulating human Fc receptor structural and functional diversity
- (2012) P. Smith et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Interaction with Fc RIIB Is Critical for the Agonistic Activity of Anti-CD40 Monoclonal Antibody
- (2011) A. L. White et al. JOURNAL OF IMMUNOLOGY
- Cancer immunotherapy comes of age
- (2011) Ira Mellman et al. NATURE
- CD40 Agonists Alter Tumor Stroma and Show Efficacy Against Pancreatic Carcinoma in Mice and Humans
- (2011) G. L. Beatty et al. SCIENCE
- Inhibitory Fc Receptor Engagement Drives Adjuvant and Anti-Tumor Activities of Agonistic CD40 Antibodies
- (2011) F. Li et al. SCIENCE
- NADPH oxidase activator p67phox behaves in solution as a multidomain protein with semi-flexible linkers
- (2009) Dominique Durand et al. JOURNAL OF STRUCTURAL BIOLOGY
- Specificity and affinity of human Fc receptors and their polymorphic variants for human IgG subclasses
- (2008) P. Bruhns et al. BLOOD
- Death receptor 5 mediated-apoptosis contributes to cholestatic liver disease
- (2008) K. Takeda et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now